Golden Throat Holdings Group Company Limited
Research Golden Throat Holdings Group Company Limited (6896.HK) on Bullrun: market cap HKD 1.41B, P/E 6.0, dividend yield 17.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6896.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 1.41B
- P/E6.0
- Dividend yield17.7%
- Financial periodFY2025
- RevenueCNY 943.26M
- Revenue growth-20.4%
- Net incomeCNY 251.20M
- Free cash flowCNY 77.99M
- Gross margin76.0%
Valuation Snapshot
latest market cap is HKD 1.41B; P/E is 6.0; dividend yield is 17.7%.
Peer valuation comparison
Latest P/E is 5.95x versus a Healthcare sector median of 21.69x (72.6% below).
Latest dividend yield is 17.71% versus a Healthcare sector median of 2.41% (634.9% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 943.26M | CNY 251.20M | CNY 77.99M | 76.0% | n/a | CNY 968.28M | CNY 584.27M | CNY 1.38B |
| FY2024 | CNY 1.19B | CNY 318.63M | CNY 408.65M | 75.5% | 0.43 | CNY 1.13B | CNY 426.92M | CNY 1.47B |
| FY2023 | CNY 961.38M | CNY 250.16M | CNY 221.30M | 72.6% | 0.34 | CNY 1.03B | CNY 412.34M | CNY 1.55B |
| FY2022 | CNY 992.01M | CNY 281.22M | CNY 255.30M | 72.7% | 0.38 | CNY 895.52M | CNY 272.59M | CNY 1.54B |
| FY2021 | n/a | n/a | n/a | n/a | 0.25 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 1.41B | 6.0 | 17.9% | 0.34 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.34 HKD, yield 17.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.5 CNY |
| FY2024 | 0.6 CNY |
| FY2023 | 0.36 CNY |
| FY2022 | 0.18 CNY |
| FY2021 | 0.06 CNY |
About Golden Throat Holdings Group Company Limited
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Golden Throat Holdings Group Company Limited's market cap?
Golden Throat Holdings Group Company Limited's market capitalization is HKD 1.41B.
What is Golden Throat Holdings Group Company Limited's P/E ratio?
Golden Throat Holdings Group Company Limited's price-to-earnings (P/E) ratio is 6.0.
Does Golden Throat Holdings Group Company Limited pay a dividend?
Golden Throat Holdings Group Company Limited has a dividend yield of 17.7%.
What does Golden Throat Holdings Group Company Limited do?
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn.